DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS
Clinical trials for DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS trials appear
Sign up with your email to follow new studies for DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New TB combo drug trial aims to shorten treatment
Disease control Recruiting nowThis study tests whether a new drug called TBD09, when used with other TB medicines, is safe and works well in adults with drug-sensitive tuberculosis (TB). About 150 people will take part. The main goals are to see how quickly the drug combination kills TB bacteria and to check …
Matched conditions: DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could vitamin B3 help beat TB? new trial launches
Disease control Recruiting nowThis phase 2 trial tests whether adding nicotinamide (a form of vitamin B3) to a standard three-drug regimen can safely and effectively treat drug-susceptible pulmonary tuberculosis. About 165 adults with newly diagnosed TB will receive one of two doses of nicotinamide plus the s…
Matched conditions: DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC